SHROOM2 levels correlated with OS in BRCA, kidney renal clear cell carcinoma (KIRC), and rectum adenocarcinoma (READ) (Fig. 2A); DSS in KIRC and sarcoma (SARC) (Fig. 2B); and PFI in KIRC, PAAD, SARC, THCA, and uveal melanoma (UVM) (Fig. 2C). Here, SHROOM2 is linked to pancreatic adenocarcinoma.